The transient receptor potential channel of melastatin 4 (TRPM4) belongs to a group of large ion receptors that are involved in countless cell signalling cascades. This unique member is ubiquitously expressed in many human tissues, especially in cardiomyocytes, where it plays an important role in cardiovascular processes. Transient receptor potential channels (TRPs) are usually constituted by intracellular N-and C-termini, which serve as mediators affecting allosteric modulation of channels, resulting in the regulation of the channel function. The TRPs tails contain a number of conserved epitopes that specifically bind the intracellular modulators. Here, we identify new binding sites for the calmodulin (CaM) and S100 calciumbinding protein A1 (S100A1), located in the very distal part of the TRPM4 N terminus. We have used chemically synthesized peptides of the TRPM4, mimicking the binding epitopes, along with fluorescence methods to determine and specify CaM-and S100A1-binding sites. We have found that the ligands binding epitopes at the TRPM4 N terminus overlap, but the interacting mechanism of both complexes is probably different. The molecular models supported by data from the fluorescence method confirmed that the complexes formations are mediated by the positively charged (R139, R140, R144) and hydrophobic (L134, L138, V143) residues present at the TRPM4 N terminus-binding epitopes. The data suggest that the molecular complexes of TRPM4/CaM and TRPM4/S100A1 would lead to the modulation of the channel functions.
Introduction
The transient receptor potential channel melastatin 4 (TRPM4) channel is a Ca 2+ -activated and voltagedependent nonselective cation channel belonging to the melastatin transient receptor potential channel (TRP) subfamily [1, 2] . The receptor is generally expressed in many cells of the cardiovascular system, such as cardiac cells of the conduction pathway and arterial and venous smooth muscle cells [2] [3] [4] . It is also involved in other physiological functions such as immune response [5, 6] , insulin secretion [7] and breathing activities [8] .
Recent studies have linked the TRPM4 gene to the following serious cardiovascular diseases: progressive familial heart block type 1 (PFHB1) [9] , isolated cardiac conduction disease (ICCD) [10] , atrio-ventricular conduction block (AVB) and right bundle branch block (RBBB) [11] . Several studies have also identified TRPM4 mutations in patients with conduction blocks and Brugada syndrome [12] . To date, ten genetic variants of TRPM4 found in patients with cardiac conduction pathologies have been reported in the literature, suggesting that this channel is an important susceptibility gene for cardiac conduction disorders in humans [13, 14] .
The TRPM4 acts in the composition of homotetramer. Like all TRPs, each monomer contains six transmembrane-spanning segments, and a selectivity filter for ions is located in the loop connecting the fifth and sixth transmembrane domains [15] [16] [17] . The cytoplasmic N-and C termini contain numerous binding regions for calmodulin (CaM), cytosolic ATP, phosphatidylinositol 4, 5-bisphosphate (PIP2) and putative phosphorylation sites for protein kinase A (PKA) and protein kinase C (PKC) [18] [19] [20] [21] . TRPM4 is capable of transporting monovalent cations [22] . The channel is exceptional among most TRP members by its ability to bind Ca 2+ directly. It is subsequently blocked by an increase of intracellular Ca 2 and it becomes impermeable for these cations [19] . The Ca 2+ sensitivity for the activation of TRPM4 is strongly regulated by several cellular factors, including receptor modulators such as calcium-binding proteins (CBPs) and PIP2 as well [19, 23] .
Calcium-binding proteins participate in calcium cell signalling pathways, contribute to the control of calcium concentration in the cytosol and calcium transport [24] . The role of calcium as a key and pivotal second messenger in cells largely depends on a wide number of heterogeneous CBPs. They have the ability to bind Ca 2+ by a specific binding motif [25] EF-hand. The two most important CBPs acting as TRPs modulators are CaM and S100A1. CaM is a ubiquitous, highly conserved 17 kDa protein functional as a monomer. It comprises two globular domains connected by an a-helix flexible linker allowing CaM to adopt different conformations [26] . Isolated CaM binds Ca 2+ within the physiological concentration range (K d = 5 9 10 À6 -10 À7 M) [27] . CaM becomes more extended with each pair of EF-hands upon Ca 2+ binding, exposing a hydrophobic patch via CaM a-helix flexible linker that is available to interact with a target receptor domain [28] . S100A1 forms a symmetric homodimer. Both monomer subunits are composed of four helices containing two EF-hand calcium-binding loops [29] . The third helix of S100A1 undergoes a large reorientation upon Ca 2+ binding represented by a shift from antiparallel to perpendicular orientation to the fourth helix of S100A1 [30, 31] . This conformational change reveals a large hydrophobic interface between the third and fourth helices of S100A1, which interact with target receptors [32] . The reported and described interactions of CaM/S00A1 with the binding domains of TRPs are based on the first step mediated by hydrophobic residues; the second specific step is the formation of noncovalent interactions between the positively and negatively charged residues of the binding partners. The known CaMand S100A-binding epitopes in TRPs contain hydrophobic residues in specific positions 1-5-10 or 1-8-14, originally called the CaM-binding motif. In the process of complex formation, the hydrophobic residues serve as primary nonspecific interaction mediators that adopt the receptor amphipathic a-helix. This first step reveals the positive amino-acid residues eligible to form a specific interaction with the ligand [33] [34] [35] [36] [37] [38] [39] [40] .
Here, we explore new TRPM4 distal N terminusbinding epitopes facilitating interactions with CaM and S100A1. These two proteins are bound to the same epitope in different ways. To investigate which amino acids are involved in complexes formations, we have used a set of chemically synthesized peptides mimicking the binding epitopes of TRPs. We have identified the clusters of hydrophobic and basic residues in the TRPM4 N terminus involved in the formation of TRPM4/CaM and TRPM4/S100A1 complexes.
Results
The identification of CaM-and S100A1-binding sites in TRPM4np
Most receptor domains interacting with CaM have recognizable CaM-binding motifs where the hydrophobic amino acids are at the 1-5-10 and/or 1-8-14 positions [40] . These hydrophobic clusters participate in the formation of an amphipathic helix during the interaction with the ligand. Consequently, a cluster of positive amino acids at the opposite site of the helix is accessible to form noncovalent interactions with the negative amino acids of the ligand. The presence of positively charged amino acids (usually three or four basic residues) which are embedded in the identified hydrophobic motif(s) and form alone the receptorligand interaction is necessary. CaM and S100A1 very often share a same binding epitope in the receptor, but the two interactions are implemented in a different way. The different character of the CaM-and S100 A1-binding mechanisms is caused by a different arrangement of the two molecules. The CaM uses the central helix to interact with the receptor domain, whereas the S100A1 utilizes the third and fourth helices to form a hydrophobic patch.
The CaM-and S100A1-binding motifs were found in the intracellular distal N terminus of human TRPM4 (UniProtKB/Swiss-Prot: Q8TD43; positions V129-Q147) by scanning the sequence using the CaM Target Database [41] . This online tool identifies a potential receptor-binding domain containing a hydrophobic residue cluster at the 1-5-10 positions (Fig. 1A) L134, L138, V143 and the cluster of three arginines R139, R140, R144 interacting with the identified CaM-binding site. It is known that the S100A1-recognized motif at TRPM4 very often overlaps with the CaM-binding site. Therefore, we used the CaM Target Database to identify the S100A1-binding site. The identified transient receptor potential channel melastatin 4 N-terminal peptide (TRPM4np) epitope (19 aa) was synthesized as a peptide and its variants were used to map CaM and S100A1 specificity (Methods) for in vitro experiments. The peptide sequence of TRPM4npWT was also used for in silico methods.
CaM and S100A1 binding of shared N-terminal TRPM4 domains
Steady-state fluorescence anisotropy measurements were used to characterize CaM-and S100A1-binding affinities of TRPM4np (Fig. 1B,C) -derived peptides through the determination of the dissociation constants of the corresponding complexes. Carboxyfluorescein-labelled TRPM4npWT was titrated with increasing amounts of CaM or S100A1 and steadystate fluorescence anisotropy was measured for each titration point. The fluorescence anisotropy of TRPM4npWT/CaM and TRPM4npWT/S100A1 increases as the complexes form due to a slower rotational diffusion of the complexes. The fraction-bound F b of TRPM4npWT was calculated. Since the specific interactions of TRPM4npWT with CaM and S100A1 are calcium-dependent [30, 33, 34, 37, 42] , we performed all measurements in the presence of 2 mM CaCl 2 in the assay buffer. The dissociation constant of the TRPM4npWT/CaM complex K D = 1.1 lM is very similar to that of TRPM4npWT/S100A1 K D = 2.5 lM (Fig. 1C) . Mean fluorescence lifetimes of the fluorescently labelled peptides and their complexes were close to 4 ns. The resulting Q factors, correcting for change in the quantum yields of the free and bound peptide, ranged from 1.01 to 1.12. Our results show that CaM and S100A1 bind TRPM4npWT with similar affinity.
The specificity of TRPM4np/CaM and TRPM4np/ S100A1 interactions To characterize the binding specificity of N-terminal TRPM4 to CaM and S100A1, we investigated the role of TRPM4np hydrophobic and basic residues involved in the interactions with CaM/S100A1 (Figs 2A and  3A) . The binding specificity of individual complexes was reached via specific amino-acid residues involved in the formation of chemical bonds between the interacting partners. The binding affinities of individual TRPM4np-derived peptides in complexes with CaM and S100A1 were determined using steady-state fluorescence anisotropy measurements using the same protocol as for the peptide derived from wild-type (WT) TRPM4 (Fig. 2B) . The binding affinity was determined based on the results from fluorescence anisotropy experiments and calculated from the Eqn (3) formula in the Methods. The fluorescence lifetimes s i of all the peptides and their complexes were constant during all the experiments with the values close to 4 ns (Fig. 3B) .
First, we performed single-alanine replacement in the TRPM4npWT for five individual residues predicted to be involved in the interactions with CBPs (L138A, R139A, R140A, V143A and R144A). Second, particular amino acids in the whole cluster of hydrophobic residues were replaced by alanines in the studied L134A/L138A/V143A peptide and positively charged residues were replaced by citruline in the R139Cit/R140Cit/R144Cit peptide to reduce the positive charge coming from the original R residues. Third, to prove the cooperation/synergy between the identified hydrophobic-and basic-residue clusters, we designed another peptide with three replaced residues (L138G/R139N/R140Q) and a peptide with five replaced residues (L138G/R139N/R140Q/V143G/ R144N).
The steady-state fluorescence anisotropy data showed that all single-alanine mutants (L138A, R139A, R140A, V143A and R144A) caused only a small decrease (approximately three times from the original value) in the binding affinity to CaM and stay almost the same for the binding affinities to S100A1 (Fig. 2C) . These peptides in the interaction with CaM proved that each individual amino-acid residue (L138, R139, R140, V143 and R144) had only a limited influence on the formation of the complex. The only exception was the peptide, where L138 had been replaced by Ala. This substitution caused almost one-order decrease of binding affinity (K D = 7.6 lM) in the CaM complex, which indicated the importance of this residue in 1-5-10 CaM-binding motif. Similarly, in the TRPM4np/S100A1 complex, the hydrophobic V143A single mutant revealed a higher, almost threefold decrease of the dissociation constant (K D = 8.4 lM). In both complexes, the replacement of these bulky hydrophobic residues significantly affected the dissociation constant. The replacement of all three hydrophobic residues in the tested peptide L134A/L138A/ V143A remarkably changed the binding affinity to CaM (K D = 59 lM), which implied the utmost importance of bulky hydrophobic residues in the amphipathic helix facilitating the interaction. On the other hand, no such effect was observed for the binding of the peptide to S100A1 (K D = 4.4 lM).
The peptide in which arginines were replaced by citruline R139Cit/R140Cit/R144Cit confirmed the importance of positively charged amino acids in the interactions with both CBPs (CaM K D = 6.7 lM, S100A1 K D = 13.9 lM), but the effect was not so strong as expected. The importance of the interplay between basic and hydrophobic clusters in TRPM4-binding epitope was proved by the peptide construct in which both the hydrophobic and charged amino acids
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Both of these peptides showed a significant drop of the binding affinity towards CaM and S100A1. These amino-acid replacements imply the synergy between the amino-acid residues present in hydrophobic (L134, L138, V143) and basic (R139, R140, R144) clusters and it can be concluded that they play the most important role in complex formation.
TRPM4np peptides and their propensity for helix formation
The electronic circular dichroism (ECD) spectrum of TRPM4npWT has not proved any well-defined secondary structure, but the negative spectral bands at 204 nm and 222 nm attest that the helical structure is partially present (Fig. 4A) . The secondary structure of all single mutants is rather similar to TRPM4npWT (Fig. 4B) . On the other hand, the ECD spectra for the basic (R139Cit/R140Cit/R144Cit) and hydrophobic (L134A/L138A/V143A) mutants with a negative band at 199 nm with a shoulder at 222 nm have shown a decrease of the a-helical structure in favour of the unordered structure unlike in TRPM4npWT (Fig. 4C) . The small spectral shift of the negative minima from 204 nm observed for TRPM4npWT to 202 nm accompanied by decrease of intensity of the negative shoulder at 222 nm observed for both triple and penta mutants has confirmed some decrease of the a-helical structure when compared to TRPM4npWT. All these structural changes for TRPM4npWT mutants indicate the distortion of the original TRPM4 peptide structure, as a result of which it will be more difficult to achieve the a-helical formation for the TRPM4np protein during the interactions with ligands. The L134, L138, R139, R140, V143 and R144 residues have proved their importance for the structural arrangement of TRPM4np needed for CaM and S100A1 complexes, as the replacement of these residues disrupted the original TRPM4np structure required for the formation of the a-helical structure to ensure proper orientations of the basic amino acids to form noncovalent interactions with ligands.
The details of CaM and S100A1 interactions with receptor-binding partners have been described earlier using structural studies [42, 43] FracƟon bound
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CBPs induced a-helical formation at the receptor-binding domain during the interactions. To verify this finding for the TRPM4np, the ECD spectroscopy was applied. The increase of the intensity of the negative spectral bands at 205 and 222 nm in the ECD spectra of the TRPM4npWT/CaM and TRPM4npWT/S100A1 reflected an increase of the a-helical fraction in the secondary structure of both complexes (Fig. 4D,E) . The differential spectra of both complexes after the subtraction of the proper ligands showed a TRPM4npWT pattern similar to that observed for WT (Fig. 4F) .
Regarding the formation of the a-helical structure of TRPM4npWT during ligand interactions, we assume that the secondary structure of the ligands does not change during these interactions. This assumption is based on their higher weight and structural stability relative to the 19 amino-acid TRPM4np peptide.
The ab initio TRPM4np molecular model docked into the CaM-and S100A1-binding sites has revealed potential binding interfaces
We have used ab initio molecular modelling and ligand docking to visualize and describe in details the potential binding modes of CBPs with TRPM4npWT. The first molecular model of the TRPM4npWT/CaM complex was built using a template of transient receptor potential channel vaniloid 1 (TRPV1)/CaM interaction [43] . The second molecular model of the TRPM4npWT/S100A1 complex was constructed using the structure of the RyR1P12 peptide from Ca 2+ -transporting rhyanodine receptor 1 (RyR1) receptor in complex with S100A1 (PDB: 2K2F) [42] . The TRPM4npWT/CaM and TRPM4npWT/S100A1 complexes were built using criteria derived from the structural analysis of TRPV1/CaM and RyR1P12/S100A1 interactions. The 3D model of the TRPM4npWT was created using the protocol described in Section Molecular modelling and ligand docking of the Methods and it was consequently docked into CaM and S100A1 proteins at the assigned binding interfaces (Fig. 5) . The orientation of ligands was further optimized by applying the criteria derived from the structural analysis of the TRPV1/CaM and RyR1P12/ S100A1 complexes. The binding interfaces of the final TRPM4npWT/CaM and TRPM4npWT/S100A1 models were almost identical to those of the previously described TRPV1/CaM and RyR1P12/S100A1 complexes [42, 43] . The cluster of hydrophilic residues (L134A, L138A, V143A) was predicted to be crucial for TRPM4np-helix stabilization as well as for the interaction, whereas the cluster of basic residues (R139A, R140A, R144A) was predicted to be exclusively important for the interaction with negativecharge residues in CaM and S100A1 (E14, E114, E127 for CaM; and D46, D50, D52, E60 for S100A1). 3D models confirmed the importance of the selected residues of TRPM4np for the CaM-and S100A1-binding interface as well as for the TRPM4npWT-helix formation and stability. The interpretation is strongly supported by data from fluorescence anisotropy experiments, which have revealed that the synergy of basic and hydrophobic residues in individual clusters is crucial for TRPM4npWT/CaM and TRPM4npWT/ S100A1 complex formation.
Discussion
Transient receptor potential channel of melastatinfamily binding regions with CaM/S100A1 have already been described. For example, the TRPM1 N terminus binds S100A1 in complex with Ca 2+ [38] , and the TRPM3-binding regions shared among CaM, S100A1 and PIP2 have been identified on both intracellular tails [37, 44] . Moreover, studies with deletion mutants of TRPM4 suggest that the CaM-binding sites on the C terminus are important for Ca 2+ -induced activation [19] . The opposite role of CaM is suggested in the inhibition of the kinase activity of TRPM7 [45] . The CaM-binding domains in TRPM2 and TRPM8 serve as a trigger area for the activation of the channel by ligand binding [32, 46] . It is plausible to expect that CaM exerts multiple regulatory roles in TRPMs and uses different mechanisms for the activation/inhibition channel function. It can be anticipated that more CaM-binding sites will be identified in different TRPs and the functional range of these interactions will be wide and complex. There is clear evidence that the 4 . ECD of TRPM4npWT, mutants and TRPM4npWT/CaM and TRPM4npWT/S100A1 complexes. The ECD spectra of (A) TRPM4npWT and its single L138A, R139A, R140A, V143A and R144A mutants; (B) TRPM4npWT and its hydrophobic L134A/L138A/V143A and basic R139Cit/R140Cit/R144Cit mutants; (C) TRPM4npWT and its triple L138G/R139N/R140Q and penta L138G/R139N/R140Q/V143G/R144N mutants; (D) a TRPM4npWT, CaM and TRPM4npWT/CaM complex; (E) a TRPM4npWT, S100A1 and TRPM4npWT/S100A1 complex; and (F) differential spectra of TRPM4npWT/CaM and TRPM4npWT/S100A1 without CaM/S100A1. receptor-binding sites of the S100A1 are very often shared with CaM, but the recognition is realized by a different mechanism. The shared CBP-binding epitopes have been reported for the TRPM3, TRPC6 and TRPV1 [33, 36, 37, 47, 48] . The interaction of the TRPV5 and TRPV6 with the S100A10/AnexinA2 complex, which mediates trafficking to the plasma membrane, has been reported as an example of TRP regulation by S100A1 in multicomplex arrangement [36, 48] . The mechanisms of TRP modulation by S100A1 are still not well described and understood. The only binding mechanism of S100A1 with a receptor peptide described in detail comes from the structural study of the S100A1/RyR [42] .
Here, we present the TRPM4 N terminus-binding domains (TRPM4np) as new overlapping binding domains for CaM and S100A1. Using steady-state fluorescence anisotropy measurements, we have determined the dissociation constants of the TRPM4np/CaM and TRPM4np/S100A1 complexes with clusters of hydrophobic L134, L138, V143 and basic R139, R140, R144 residues involved in the interactions. The dissociation constants of TRPM4np WT with CaM and S100A1 were in a comparable micromolar range for both complexes, which corresponds to the data of previous binding affinities measured for other TRP/CaM and TRP/S100A1 complexes [33, 34, 37] . Using steadystate fluorescence anisotropy measurements, we determined the dissociation constants of the TRPM4np/ CaM and TRPM4np/S100A1 complexes. We paid particular attention to the importance of the clusters of hydrophobic L134, L138, V143 and basic R139, R140, R144 residues predicted to facilitate the interaction. The dissociation constants of TRPM4np WT with CaM and S100A1 were in a comparable micromolar range for both complexes. The CaM and S100A1 interactions depend on the formation of hydrophobic clefts in both CBPs, which also facilitate or promote helix formation of the recognized epitope and are always Ca 2+ dependent [42, 43] . The Ca 2+ dependence of TRP/CaM or TRP/S100A1 interactions was validated in our previous experiments [33] [34] [35] 37] , which made it possible to use buffers with 2 mM of CaCl 2 in our binding assays. The replacement of selected amino acids in the synthesized peptides has proved that interactions in both complexes are facilitated by the same amino-acid residues. On the other hand, the different binding affinities of the mutants have indicated that the mechanism of ligand binding is different, which has been supported by results of molecular modelling. Mutual competitions of CaM and S100A1 for the overlapping binding of TRPs on N-and C-termini and RyR have already been characterized [34, 35, 37, 42] .
The ECD data have confirmed the importance of the cluster of selected hydrophobic and basic residues, which stabilizes the receptor-binding domain and creates a disordered prebinding interface. This is consequently facilitated by the formation of the TRPM4np amphipathic helix with the final creation of noncovalent interactions. The ECD data obtained for CaM/ S100A1 in the presence of TRPM4np have also confirmed an increase of a-helical content in both complexes, which indicates the increase or formation of the a-helical conformation of the TRPM4np peptide during the interactions. This phenomenon is commonly observed in CaM/S100A1 calcium-dependent interactions [42, 43] .
Analyses of interactions in the CaM/TRPM4np model and the S100A1/RyR1P12 structure have corroborated the suggested role of TRPM4np hydrophobic and basic residues for complex formation. The binding interface of TRPM4np/CaM clearly shows the importance of L134A, L138A and V143A hydrophobic residues for the interaction with the hydrophobic residues of the central a-helix of the CaM. The corresponding hydrophobic residues at the CaM central helix very likely help to induce TRPM4np helix formation and stabilize it by hydrophobic interactions. The helix then exposes the basic R139A, R140A and R144A residues to form noncovalent interactions with negatively charged residues of CaM. The binding interface of the TRPM4np/S100A1 complex is facilitated by the same clusters of hydrophobic and basic residues of TRPM4np, but the binding mode is different. Interactions of the complex are maintained by TRPM4np hydrophobic residues, which are in contact with a large hydrophobic patch of the third and fourth helices of S100A1 formed upon Ca 2+ binding. The models also suggest that the orientation of TRPM4np on S100A1 is different from that in other S100-peptide complexes, in which peptides align in parallel with helix 3. We suppose that the TRPM4np amphipathic helix formation in the TRPM4np/S100A1 complex is less needed than in the interaction of the TRPM4 with CaM. On the other hand, the TRPM4np basic residues R139A, R140A and R144A are clearly responsible for noncovalent interactions with the negatively charged residues present in the third and fourth helices of S100A1 as confirmed by experimental data. The same motif for S100A1 interactions was observed previously [42] , and so was the shared sequence epitope involved in the interactions with the ligand.
Although some of the TRPs structures have already been solved [15] [16] [17] [49] [50] [51] , it is impossible to obtain the complete TRP structure including the whole intracellular N-and C-termini because of their disordered character. The disordered character of the termini determined by prediction tools is further enhanced by the fact that the intracellular tails of TRPs have very low sequence similarity. The reason why the termini of TRPs are disordered is probably their structural variability, dependent on the binding partner. This partner can further modulate the TRP structure and subsequently the channel. Our results suggest that the disordered state of unbound TRPM4np peptide utilizes the structural plasticity to reach the a-helical content needed for interactions with CBPs. In the CaM/ S100A1 complex, the CaM-binding domain facilitates the mutual orientations of the positively charged residues R139A, R140A and R144A to form specific noncovalent interactions with ligand-binding partners.
In the present study, we have shown that CaM and S100A1 specifically interact with a well-defined sequence epitopes of the TRPM4 distal N terminus. The analysis of the binding based on the nature of the amino-acid residues from this region (TRPM4np) has revealed several hydrophobic and noncovalent interactions at the interaction interface, which is shared by both CBPs. Detailed ab initio atomistic analysis of the binding interfaces has shown the distinct participation and role of identified TRPM4 amino acids in the interaction with CaM and S100A1. These two newly characterized complexes of TRPM4np/CaM and TRPM4np/S100A1 show an overlap of their binding epitopes. This finding could help to reveal new mechanism of structural modulations of TRPM4 and leads to a better understanding of the function and regulation of TRPs.
Methods
Peptide synthesis and labelling
The peptides derived from a sequence of TRPM4np (TRPM4: UniProtKB/Swiss-Prot: Q8TD43 positions V129-Q147; np: N-terminal derived peptide) were synthesized by the solid-phase peptide synthesis technique according to the standard N a -Fmoc protocol. They were prepared on a Ten- 
Protein preparation
The cDNAs of human CaM and S100A1 were subcloned into pET3a (CaM) and pET_28b (S100A1) expression vectors. The proteins were expressed in Escherichia coli BL21 cells by inducing with isopropyl-1-thio-b-D-galactopyranoside (0.5 mM) at 25°C for 12 h. CBPs were purified using affinity chromatography (5 mM of CaCl 2 were added to the supernatant) on Phenyl Sepharose CL4B (Amersham Biosciences, Little Chalfont, UK) and eluted using a buffer containing 50 mM of Tris-HCl (pH 7.5), 1.5 mM of EDTA and 100 mM of NaCl. The second purification step was performed by size-exclusion chromatography on a Superdex 75 column (Amersham Biosciences). Proteins were eluted into a buffer containing 50 mM of Tris-HCl (pH 7.0), 250 mM of NaCl, 2 mM of CaCl 2 and 2 mM of b-mercaptoethanol. The concentration of purified CBPs was determined by UV absorption at 280 nm using an extinction coefficient value of 2950 M À1 Ácm À1 for CaM and 8480 M À1 Ácm À1 for S100A1.
The purity of proteins was verified by 15% SDS/PAGE.
Fluorescence anisotropy measurements
Fluorescence anisotropy experiments were performed on a K2 spectrofluorometer (ISS, Inc., Champaign, IL, USA) at 25°C in a cuvette with a 2-mm path length. The anisotropybinding assays were performed in a 25 mM Tris-HCl (pH 7.5) buffer containing 250 mM NaCl and 2 mM CaCl 2 . TRPM4np labelled by carboxyfluorescein was titrated alternatively by small aliquots of CaM and S100A1. Fluorescence was excited at 490 nm and polarized emission components I II and I ⊥ , required for the construction of the emission anisotropy, were acquired and averaged quasi-simultaneously at 535 nm by repetitive switching of the emission polarizer. Any residual scattered light was suppressed by a long-pass dielectric filter (520 nm) placed in front of the input slit of the emission monochromator. The anisotropy value r was calculated from the fluorescence intensities in the parallel (I II ) and perpendicular (I ⊥ ) directions according to the relationship r = (I II À I ⊥ )/(I II + 2I ⊥ ) [52] . The measurements were repeated at least five times at each CaM and S100A1 concentration; the mean anisotropy value was calculated and used for further analysis. The fractions F B of bound CaM and S100A1 were evaluated as [53] :
where Q is the quantum-yield ratio of the bound to the free form of the labelled peptide, r max is the anisotropy of the complex at saturation, r min is the minimum anisotropy for the free TRPM4np, and r obs is the measured anisotropy at any intermediate CaM or S100A1 concentration. The Q was evaluated for every binding experiment from the ratio of the fluorescence lifetimes of the bound to the free TRPM4np, Q = s bound /s free . Lifetimes were evaluated at room temperature in a drop placed on a coverslip and inserted in an inverted confocal microscope IX83 (Olympus, Tokyo, Japan) equipped with TimeHarp 260 PICO time-correlated single photon counting electronics and cooled GaAsP hybrid detectors (all PicoQuant, Berlin, Germany). TRPM4np fluorescence was excited at 485 nm by an LDH-485 picosecond laser (PicoQuant). Emission decays were collected in the epifluorescence mode using a combination of a 488 nm dichroic long-pass (Olympus) filter and a Semrock 520/35 bandpass filter in the detection path. Intensity-weighted mean fluorescence lifetimes used in calculation of the Q correction factor were evaluated as:
where s i and a i are fluorescence lifetimes and the corresponding amplitudes, respectively. To determine the equilibrium dissociation constants K D , F B was plotted as a function of CaM or S100A1 concentration and fitted by [54] :
where [P1] represents the TRPM4np concentration and [P2] is the CaM or S100A1 concentration. Nonlinear data fitting was performed using SIGMAPLOT 11.0 (Systat software, Inc., San Jose, CA, USA).
Electronic circular cichroism
The ECD spectra of proteins and peptides were measured on a Jasco J-815 spectropolarimeter (Jasco Corporation, Tokyo, Japan). The samples were measured in the spectral range of 200-300 nm using a quartz cell with a 0.05-cm path length and the following setup: the standard instrument sensitivity, the scanning speed of 5 nmÁmin À1 , the response time of 16 s, and two spectrum accumulations).
The ECD was performed in a 25 mM Tris-HCl (pH 7.5) buffer containing 250 mM NaCl and 2 mM CaCl 2 . The obtained spectra were expressed in terms of molar ellipticity h (deg.cm 2 .dmol À1 ) per residue [55] .
Molecular modelling and ligand docking
A molecular model of the TRPM4npWT was generated ab initio using the Psi-pred prediction server [56] . The final TRPM4npWT model was carefully chosen based on the requirement for basic and hydrophobic residues to be exposed to the solvent, and also on geometric constraints in the potential CaM-and S100A1-binding sites. The quality of the resulting structure was assessed using STING Millenium [57] and ProSA-web [58] . 3D refine freeware [59] was used for hydrogen bonding network optimization and atomic-level energy minimization. The ligand docking of CaM and S100A1 (CaM/Ca 2+ monomer in complex with TRPV1 peptide -PDB code 2LP3; and S100A1/Ca 2+ dimer in complex with RyR1 peptide -PDB code 2K2F) into the TRPM4npWT molecular model was performed using the program pyDockWeb [60] . The schematic representations of the TRPM4npWT/CaM and TRPM4npWT/S100A1 complexes were generated using Chimera freeware [61] .
